Colorectal Neoplasms: all 5,738 studies
Page 8 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan StudyRecruitingNCT06719206Not applicable
- Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal CancerRecruitingNCT06718738Phase 1
- A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal CancerRecruitingNCT06717880Phase 1
- The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
- Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal CancerRecruitingNCT06714903
- ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal CancerRecruitingNCT06714357Phase 2
- SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReeningRecruitingNCT06714318
- ScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study ProtocolNot yet recruitingNCT06710860Not applicable
- Lead-212 PSV359 Therapy for Patients With Solid TumorsRecruitingNCT06710756Phase 1/2
- The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.Not yet recruitingNCT06710561Phase 1
- A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal CancerEnrolling by invitationNCT06710314
- Lynch Syndrome X-Talk of Enteral Mucosa With Immune SystemRecruitingNCT06708429
- Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer DetectionRecruitingNCT06703632Not applicable
- Intraoperative Hyperspectral Imaging for Laparoscopic SurgeryNot yet recruitingNCT06700317Not applicable
- Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal CancerRecruitingNCT06698757Phase 2
- Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed ResectionRecruitingNCT06698146
- Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal CancerRecruitingNCT06696768Phase 1
- Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening ProgrammeRecruitingNCT06696534Not applicable
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After SurgeryNot yet recruitingNCT06690606
- Faecal Immunochemical Tests (FIT) for Surveillance After Colorectal Cancer (CRC) StudyRecruitingNCT06689293
- Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal CancerNot yet recruitingNCT06688110Not applicable
- COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal CancerRecruitingNCT06685497Not applicable
- Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal CancerRecruitingNCT06685276Phase 2
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionRecruitingNCT06682793Phase 1/2
- Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)RecruitingNCT06682650Not applicable
- Single cEll pRofiling PErsistaNce To ImmuNothErapyRecruitingNCT06680739Phase 2
- SHR-1701 Combined with SHR2554 and BP102 for MCRCNot yet recruitingNCT06679673Phase 2
- AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and BeyondRecruitingNCT06678919
- Understanding Sugar-Sweetened Beverages (SSB) and Colorectal Cancer (CRC)Not yet recruitingNCT06669923Not applicable
- The Ohio State University (OSU) SCREEN Community ProgramRecruitingNCT06666192Not applicable
- SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal CancerNot yet recruitingNCT06666166Phase 2
- To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer SurgeryNot yet recruitingNCT06665334Phase 4
- Impact of a Proactive Strategy of General Practitioners on CRC ScreeningNot yet recruitingNCT06664567
- A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal CancerRecruitingNCT06663839Phase 1
- A Study of JNJ-89402638 for Metastatic Colorectal and Gastric CancersRecruitingNCT06663319Phase 1
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerRecruitingNCT06662786Phase 3
- A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsRecruitingNCT06657144Phase 1
- The PharmFIT StudyNot yet recruitingNCT06656936Not applicable
- OSCAR II STUDY - The ONCObind CTC Removal StudyNot yet recruitingNCT06655142Not applicable
- Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal CancerRecruitingNCT06654037Phase 1
- Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid TumorsNot yet recruitingNCT06652529Phase 1
- Triple Assay of Rectal Mucus in the Diagnosis of Colorectal CancerRecruitingNCT06649123
- Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) TrialRecruitingNCT06646809Phase 3
- EMVI as a Determinant of Metastasis in Colorectal CancerRecruitingNCT06646341
- DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR KitRecruitingNCT06645236Not applicable
- Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRCRecruitingNCT06643793Phase 2
- Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.RecruitingNCT06640166Phase 2
- Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal CancerRecruitingNCT06637215Not applicable
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)RecruitingNCT06634875Phase 2
- Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLMRecruitingNCT06630624Phase 1/2
- 6-year Follow-up Data After the Berberine Intervention TrialRecruitingNCT06629051
- Clinical and Endoscopic Characterization of Patients With Multiple Colorectal Adenomas: A Multicenter Study in Spain (ESPAPOLYP Study)Not yet recruitingNCT06625788
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsRecruitingNCT06625775Phase 1
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC PatientsRecruitingNCT06621173Early Phase 1
- Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer DetectionRecruitingNCT06620627
- Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent TreatmentRecruitingNCT06617858Phase 2
- First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III StudyNot yet recruitingNCT06616259Phase 3
- Effectiveness of a PMT Intervention to Reduce Alcohol in Young AdultsNot yet recruitingNCT06615648Not applicable
- A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNot yet recruitingNCT06614751Phase 1
- Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)RecruitingNCT06614738
- RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-basedRecruitingNCT06614647Not applicable
- Patient-led Follow-up from Home After Surgery for Colorectal CarcinomaRecruitingNCT06613581Not applicable
- Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal CancerRecruitingNCT06613165
- Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.RecruitingNCT06613113Not applicable
- Evaluation of Gixam's Performance in a FIT Negative PopulationRecruitingNCT06612281Phase 2
- A Predictive Model Based on Quantitative Fecal Immunochemical Test Can Stratify the Risk of CRC in an Organized Screening ProgramNot yet recruitingNCT06607614
- Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant DiseaseRecruitingNCT06607458Phase 2
- Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-ColonoscopyEnrolling by invitationNCT06603519Not applicable
- Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal CancerRecruitingNCT06603376Phase 2
- The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)RecruitingNCT06601075
- A Study to Determine the Effect of CT3001 in Patients With Advanced Solid TumorsRecruitingNCT06598007Phase 1/2
- Large-Scale Implementation of a Decision Aid About Colorectal Cancer ScreeningEnrolling by invitationNCT06597955
- Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal CancerNot yet recruitingNCT06596343Phase 2
- Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal CancerNot yet recruitingNCT06593548Phase 2
- A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLMRecruitingNCT06590259Phase 2
- TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal CancerRecruitingNCT06589830Phase 2
- Microbiome Testing for the Screening of Colorectal CancerRecruitingNCT06588166
- Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical SystemEnrolling by invitationNCT06587152Not applicable
- Exploratory Study of Intermittent Hypoxia Intervention on Colorectal CancerRecruitingNCT06584318Not applicable
- The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal CancerEnrolling by invitationNCT06583564Not applicable
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health CentersRecruitingNCT06568016Not applicable
- Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal CancerRecruitingNCT06566755Phase 3
- The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL TrialRecruitingNCT06565052Not applicable
- FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal CancerRecruitingNCT06563986Phase 2
- A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerRecruitingNCT06562543Phase 4
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal CancersRecruitingNCT06562192Phase 1
- Multidimensional Examination of Patients with Colorectal and Anal CancerRecruitingNCT06562140
- Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans AffairsRecruitingNCT06559059Not applicable
- GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.RecruitingNCT06558773Phase 2
- An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous PolyposisRecruitingNCT06557733Phase 2
- Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal CancerRecruitingNCT06557668
- DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver MetastasesRecruitingNCT06555003Phase 3
- Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCCRecruitingNCT06553885Phase 2
- ElastoMRI Evaluation of Hepatic Metastases in Colorectal Cancer ( MetaIRM)Not yet recruitingNCT06552117Not applicable
- Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRCRecruitingNCT06551207Not applicable
- A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic TherapyRecruitingNCT06549907
- Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer StudyRecruitingNCT06547203Phase 2
- Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver MetastasesRecruitingNCT06545630Phase 1